A validated hypoxia-inducible factor (HIF) signature across tissue compartments predicts clinical outcome in human lung fibrosis

Yilu Zhou, Rob M. Ewing, Donna E. Davies, Yihua Wang, Mark G. Jones
doi: https://doi.org/10.1101/2022.01.11.22269085

Article Information

doi 
https://doi.org/10.1101/2022.01.11.22269085
History 
  • January 12, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Yilu Zhou1,2,
  2. Rob M. Ewing1,2,
  3. Donna E. Davies2,3,4,
  4. Yihua Wang1,2,4,5,† and
  5. Mark G. Jones2,3,4,5,†
  1. 1Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton SO17 1BJ, UK
  2. 2Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, UK
  3. 3Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton SO16 6YD, UK
  4. 4NIHR Respiratory Biomedical Research Centre, University Hospital Southampton SO16 6YD, UK
  1. ↵5Correspondence should be addressed to M.G.J. (e- mail: mark.jones{at}soton.ac.uk) or Y.W. (e-mail: yihua.wang{at}soton.ac.uk).

  1. ↵† Senior authors contributed equally to this work

Back to top
Posted January 12, 2022.
Download PDF
Data/Code
Email
A validated hypoxia-inducible factor (HIF) signature across tissue compartments predicts clinical outcome in human lung fibrosis
Yilu Zhou, Rob M. Ewing, Donna E. Davies, Yihua Wang, Mark G. Jones
medRxiv 2022.01.11.22269085; doi: https://doi.org/10.1101/2022.01.11.22269085
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area